Article
CTCs‐derived xenograft development in a triple negative breast cancer case
19 Nov 2018
Abstract excerpt
Triple-negative breast cancer (TNBC) is characterized by high rates of metastasis and no available molecular targets. CTCs derived xenografts (CDX) have demonstrated to be a promising tool for understanding cancer biology. In our study, a CDX from a TNBC patient was developed for the first time. After CDX characterization, WNT signaling was found as the main mechanism related with this tumor biology and potential...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
